Lab test used to calculate CURB-65 score for mortality in pneumonia
BUN
FEV1/FVC ratio defining airway obstruction
<0.7
Name for elevated intraocular pressure without damage to optic nerve
Ocular hypertension
Microvascular complication of diabetes which worsens during pregnancy
Retinopathy
USPSTF recommends screening for depression in this population
All adults regardless of risk factors
MAC prophylaxis is no longer recommended due to low incidence
French word for "rattle" describing a lung auscultation finding
Rales
Name for bacterial infection of the globe and vitreous humor
Endophthalmitis
Most common pituitary cause of secondary amenorrhea
Prolactinoma
Lung cancer screening is done for adults with history of smoking and in this age range
50-80 years
This eponymous syndrome is characterized by shock, multi organ failure, disseminated intravascular coagulation with widespread purpura and rapidly developing adrenocortical insufficiency in bacterial infection
Waterhouse-Friderichsen syndrome
Pulmonary artery pressure threshold used to define pulmonary hypertension
> 20 mmHg
Medical term for different colored iris in each eye
Heterochromia iridium
Common benign mass at vaginal introitus
Bartholin's cyst
USPSTF recommends stopping PSA testing for prostate cancer screening in men above this age
men >70 years
RECOVERY trial
FDA approved therapies for ILD
Nintedanib and pirfenidone
The Schirmer test may be used to evaluate this autoimmune inflammatory disorder
Sjogren syndrome
Safest anti epileptic drugs in women of childbearing age
Levetiracetam and lamotrigine
USPSTF assigns this grade of evidence to starting a statin in adults age 76 years or older
Grade I (insufficient evidence)
Post exposure prophylaxis for inhalational anthrax
ciprofloxacin
Two parameters used to calculate the rapid shallow breathing index to assess readiness for extubation
Respiratory rate and tidal volume
Tamsulosin
FDA approved medication for emergency contraception within 5 day window from intercourse
Ulipristal
Recommendation for maternal RSV vaccine (ABRYSVO) was newly introduced in September 2023 for pregnant women in this gestational age to lower RSV lower respiratory tract infections in infant
32-36 weeks gestation